Cargando...
Biomarker development in the precision medicine era: lung cancer as a case study
Precision medicine relies on validated biomarkers with which to better classify patients by their probable disease risk, prognosis and/or response to treatment. Although affordable ‘omics’-based technology has enabled faster identification of putative biomarkers, the validation of biomarkers is stil...
Gardado en:
| Publicado en: | Nat Rev Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6662593/ https://ncbi.nlm.nih.gov/pubmed/27388699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc.2016.56 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|